Biotech company Metsera, which develops weight-loss drugs and is backed by ARCH Venture Partners, said on Monday that it is ...

Drug developer Maze Therapeutics said on Monday it was targeting a valuation of as much as $728.1 million in its initial ...

Czech steam-turbine manufacturer Doosan Skoda Power AS launched an initial public offering, touting an outlook for high ...

Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a ...

Snag is, Cheniere’s two export terminals are already advanced enough to generate several billion dollars in cash flow, much of which is already flowing in dividends to shareholders. Venture Global is ...

Metsera has set its sights on a hefty $289 million IPO as the next-gen obesity biotech seeks to fund a phase 3 trial of its ...

Venture Global's IPO represents a test for investor appetite for fossil fuel projects in the Trump administration.

More generally, markets have a way of recalibrating, and Venture Global’s IPO offers a nuanced lesson. It’s a reminder that valuations aren’t fixed by management or banker decree, but rather hammered ...

Ratio Speciality Co. issued today, Jan. 27, a prospectus to sell 5 million shares, or 25% of capital, in an initial public ...

Venture Global, a producer of liquified natural gas, made its stock market debut on Friday as President Trump plans to boost ...

Then Wiz came along. Wiz CEO and cofounder Assaf Rappaport, hangs out in the social circle of some of their mutual ...

Leading fintech firm Pine Labs is gearing up to file its initial public offering (IPO) documents by mid-February. The company ...